In the version of this article initially published, the Competing Interests declaration was incorrect. The correct declaration is “L.H.G. is a former director of Bristol-Myers Squibb and the Waters Corporation and is currently on the board of directors of GlaxoSmithKline Pharmaceuticals and Analog Devices, Inc. She also serves on the scientific advisory boards of Repare Therapeutics, Abpro Therapeutics and Kaleido Therapeutics. A.-H.L. is an employee of Regeneron Pharmaceuticals and holds stock options in the company.” The error has been corrected in the HTML and PDF versions of the article.
|Original language||English (US)|
|Number of pages||1|
|State||Published - Jan 2021|
Bibliographical notePublisher Copyright:
© 2020, The Author(s), under exclusive licence to Springer Nature America, Inc.
PubMed: MeSH publication types
- Published Erratum